nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—conduct disorder	0.874	1	CbGaD
Zuclopenthixol—DRD5—Dopamine receptors—DRD4—conduct disorder	0.0129	0.112	CbGpPWpGaD
Zuclopenthixol—DRD1—Dopamine receptors—DRD4—conduct disorder	0.0086	0.0743	CbGpPWpGaD
Zuclopenthixol—DRD2—Dopamine receptors—DRD4—conduct disorder	0.0065	0.0561	CbGpPWpGaD
Zuclopenthixol—HTR6—Serotonin receptors—HTR2A—conduct disorder	0.00324	0.0279	CbGpPWpGaD
Zuclopenthixol—DRD5—Monoamine GPCRs—DRD4—conduct disorder	0.00286	0.0247	CbGpPWpGaD
Zuclopenthixol—DRD5—Amine ligand-binding receptors—DRD4—conduct disorder	0.00241	0.0208	CbGpPWpGaD
Zuclopenthixol—HTR6—Monoamine GPCRs—DRD4—conduct disorder	0.00221	0.0191	CbGpPWpGaD
Zuclopenthixol—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00206	0.0178	CbGpPWpGaD
Zuclopenthixol—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00195	0.0168	CbGpPWpGaD
Zuclopenthixol—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.0019	0.0164	CbGpPWpGaD
Zuclopenthixol—DRD5—Monoamine GPCRs—HTR2A—conduct disorder	0.00187	0.0161	CbGpPWpGaD
Zuclopenthixol—HTR6—Amine ligand-binding receptors—DRD4—conduct disorder	0.00186	0.016	CbGpPWpGaD
Zuclopenthixol—DRD5—G alpha (s) signalling events—CGA—conduct disorder	0.00177	0.0153	CbGpPWpGaD
Zuclopenthixol—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0016	0.0138	CbGpPWpGaD
Zuclopenthixol—DRD5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00157	0.0135	CbGpPWpGaD
Zuclopenthixol—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00147	0.0127	CbGpPWpGaD
Zuclopenthixol—HTR6—Monoamine GPCRs—HTR2A—conduct disorder	0.00144	0.0124	CbGpPWpGaD
Zuclopenthixol—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00144	0.0124	CbGpPWpGaD
Zuclopenthixol—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00141	0.0122	CbGpPWpGaD
Zuclopenthixol—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.00141	0.0122	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.00138	0.0119	CbGpPWpGaD
Zuclopenthixol—HTR6—G alpha (s) signalling events—CGA—conduct disorder	0.00137	0.0118	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.00128	0.0111	CbGpPWpGaD
Zuclopenthixol—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.00124	0.0107	CbGpPWpGaD
Zuclopenthixol—HTR6—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00121	0.0105	CbGpPWpGaD
Zuclopenthixol—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00121	0.0104	CbGpPWpGaD
Zuclopenthixol—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00119	0.0102	CbGpPWpGaD
Zuclopenthixol—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00118	0.0102	CbGpPWpGaD
Zuclopenthixol—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.00118	0.0102	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00116	0.01	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00108	0.00932	CbGpPWpGaD
Zuclopenthixol—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00104	0.009	CbGpPWpGaD
Zuclopenthixol—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000937	0.00808	CbGpPWpGaD
Zuclopenthixol—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.000919	0.00794	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000902	0.00779	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000845	0.00729	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.000838	0.00724	CbGpPWpGaD
Zuclopenthixol—Flupentixol—HTR2A—conduct disorder	0.000799	0.0775	CrCbGaD
Zuclopenthixol—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000787	0.0068	CbGpPWpGaD
Zuclopenthixol—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000773	0.00667	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000758	0.00655	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000743	0.00641	CbGpPWpGaD
Zuclopenthixol—Amoxapine—DRD4—conduct disorder	0.000738	0.0716	CrCbGaD
Zuclopenthixol—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000705	0.00608	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000652	0.00563	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—CGA—conduct disorder	0.000643	0.00555	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000627	0.00542	CbGpPWpGaD
Zuclopenthixol—Nefazodone—SLC6A4—conduct disorder	0.000581	0.0564	CrCbGaD
Zuclopenthixol—Loxapine—DRD4—conduct disorder	0.000576	0.0559	CrCbGaD
Zuclopenthixol—Quetiapine—DRD4—conduct disorder	0.000563	0.0546	CrCbGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000561	0.00484	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000552	0.00477	CbGpPWpGaD
Zuclopenthixol—Trazodone—SLC6A4—conduct disorder	0.000537	0.0521	CrCbGaD
Zuclopenthixol—HTR6—GPCR ligand binding—CGA—conduct disorder	0.000497	0.00429	CbGpPWpGaD
Zuclopenthixol—Clozapine—DRD4—conduct disorder	0.000484	0.0469	CrCbGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000476	0.00411	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000473	0.00408	CbGpPWpGaD
Zuclopenthixol—Chlorpromazine—DRD4—conduct disorder	0.000455	0.0442	CrCbGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000448	0.00387	CbGpPWpGaD
Zuclopenthixol—Nefazodone—HTR2A—conduct disorder	0.000446	0.0433	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—conduct disorder	0.000443	0.043	CrCbGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000434	0.00374	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000427	0.00369	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000426	0.00368	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000424	0.00366	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000417	0.0036	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000416	0.00359	CbGpPWpGaD
Zuclopenthixol—Trazodone—HTR2A—conduct disorder	0.000413	0.0401	CrCbGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000408	0.00352	CbGpPWpGaD
Zuclopenthixol—Thioproperazine—HTR2A—conduct disorder	0.000393	0.0382	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—conduct disorder	0.000387	0.0376	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—conduct disorder	0.000387	0.0376	CrCbGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000379	0.00327	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000367	0.00317	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000365	0.00315	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CGA—conduct disorder	0.000364	0.00314	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00036	0.00311	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—DRD4—conduct disorder	0.00036	0.00311	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00036	0.00311	CbGpPWpGaD
Zuclopenthixol—Loxapine—SLC6A4—conduct disorder	0.000346	0.0336	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—conduct disorder	0.00034	0.033	CrCbGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000338	0.00292	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000337	0.00291	CbGpPWpGaD
Zuclopenthixol—Fluphenazine—HTR2A—conduct disorder	0.000335	0.0325	CrCbGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CGA—conduct disorder	0.00033	0.00285	CbGpPWpGaD
Zuclopenthixol—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000329	0.00284	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000326	0.00282	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000323	0.00279	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000318	0.00274	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000317	0.00273	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000314	0.00271	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000311	0.00268	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000309	0.00266	CbGpPWpGaD
Zuclopenthixol—Chlorprothixene—HTR2A—conduct disorder	0.000305	0.0296	CrCbGaD
Zuclopenthixol—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000298	0.00258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000289	0.00249	CbGpPWpGaD
Zuclopenthixol—Thioridazine—HTR2A—conduct disorder	0.000288	0.028	CrCbGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CGA—conduct disorder	0.000281	0.00242	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000278	0.0024	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—DRD4—conduct disorder	0.000278	0.0024	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000277	0.00239	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000273	0.00235	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000272	0.00235	CbGpPWpGaD
Zuclopenthixol—Trifluoperazine—HTR2A—conduct disorder	0.000267	0.0259	CrCbGaD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000267	0.00231	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000267	0.0023	CbGpPWpGaD
Zuclopenthixol—Loxapine—HTR2A—conduct disorder	0.000266	0.0258	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—conduct disorder	0.000265	0.0257	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2A—conduct disorder	0.000259	0.0252	CrCbGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000255	0.0022	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000248	0.00214	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000242	0.00208	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000239	0.00207	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000239	0.00207	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000238	0.00206	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000237	0.00205	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—HTR2A—conduct disorder	0.000235	0.00203	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000234	0.00202	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000233	0.00201	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00023	0.00198	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000229	0.00197	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000225	0.00194	CbGpPWpGaD
Zuclopenthixol—Clozapine—HTR2A—conduct disorder	0.000223	0.0216	CrCbGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000219	0.00189	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000212	0.00183	CbGpPWpGaD
Zuclopenthixol—Chlorpromazine—HTR2A—conduct disorder	0.00021	0.0204	CrCbGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000205	0.00177	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000205	0.00177	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.000204	0.00176	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000201	0.00174	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CGA—conduct disorder	0.000195	0.00168	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—DRD4—conduct disorder	0.000185	0.0016	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000182	0.00157	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000181	0.00157	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000181	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000181	0.00156	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00018	0.00155	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000179	0.00155	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000179	0.00155	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000179	0.00154	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000178	0.00153	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000178	0.00153	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000177	0.00153	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000177	0.00153	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000176	0.00152	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000174	0.0015	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000174	0.0015	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000166	0.00143	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000163	0.00141	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000163	0.00141	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CGA—conduct disorder	0.000163	0.0014	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000162	0.0014	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000162	0.0014	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00016	0.00138	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.000157	0.00136	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—WASF1—conduct disorder	0.000156	0.00135	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.000156	0.00135	CbGpPWpGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000155	0.00134	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000155	0.00134	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000152	0.00131	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CGA—conduct disorder	0.000151	0.0013	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000149	0.00129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000148	0.00128	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.000143	0.00123	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000141	0.00122	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000139	0.0012	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000135	0.00117	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	0.000133	0.00115	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CGA—conduct disorder	0.00013	0.00112	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.000123	0.00106	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—WASF1—conduct disorder	0.000121	0.00104	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—HTR2A—conduct disorder	0.000121	0.00104	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000118	0.00102	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000117	0.00101	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.000116	0.000999	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000114	0.000981	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—DRD4—conduct disorder	0.000109	0.000943	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000106	0.000911	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CGA—conduct disorder	0.000105	0.000904	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—WASF1—conduct disorder	0.000104	0.000896	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	0.000103	0.000885	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000102	0.000882	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	0.0001	0.000867	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—DRD4—conduct disorder	0.0001	0.000866	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	9.84e-05	0.000849	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CGA—conduct disorder	9.78e-05	0.000844	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CGA—conduct disorder	9.63e-05	0.000831	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CGA—conduct disorder	9.61e-05	0.000829	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CGA—conduct disorder	9.43e-05	0.000814	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—HTR2A—conduct disorder	9.31e-05	0.000804	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.27e-05	0.000801	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	9.14e-05	0.000789	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—DRD4—conduct disorder	9.13e-05	0.000788	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—DRD4—conduct disorder	9.11e-05	0.000786	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	8.94e-05	0.000771	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	8.83e-05	0.000762	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CGA—conduct disorder	8.76e-05	0.000756	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DRD4—conduct disorder	8.43e-05	0.000728	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	8.3e-05	0.000717	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—HTR2A—conduct disorder	8.01e-05	0.000692	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—WASF1—conduct disorder	7.84e-05	0.000677	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.71e-05	0.000666	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—WASF1—conduct disorder	7.7e-05	0.000664	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—WASF1—conduct disorder	7.55e-05	0.000652	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—DRD4—conduct disorder	7.26e-05	0.000626	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—HTR2A—conduct disorder	7.13e-05	0.000615	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—WASF1—conduct disorder	7.02e-05	0.000606	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CGA—conduct disorder	6.82e-05	0.000589	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.66e-05	0.000575	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	6.54e-05	0.000565	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	6.42e-05	0.000554	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—HTR2A—conduct disorder	6.05e-05	0.000522	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	5.97e-05	0.000515	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—HTR2A—conduct disorder	5.94e-05	0.000513	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	5.83e-05	0.000503	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HTR2A—conduct disorder	5.5e-05	0.000475	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DRD4—conduct disorder	5.48e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	5.42e-05	0.000468	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.39e-05	0.000465	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DRD4—conduct disorder	5.38e-05	0.000464	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DRD4—conduct disorder	5.28e-05	0.000456	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—EP300—conduct disorder	5e-05	0.000432	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD4—conduct disorder	4.9e-05	0.000423	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR2A—conduct disorder	4.73e-05	0.000409	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—COMT—conduct disorder	4.73e-05	0.000408	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MAOA—conduct disorder	4.69e-05	0.000405	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EP300—conduct disorder	3.78e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.57e-05	0.000309	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2A—conduct disorder	3.51e-05	0.000303	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	3.44e-05	0.000297	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	3.2e-05	0.000276	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—COMT—conduct disorder	3.08e-05	0.000266	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MAOA—conduct disorder	3.06e-05	0.000264	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EP300—conduct disorder	2.91e-05	0.000252	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EP300—conduct disorder	2.51e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—EP300—conduct disorder	2.03e-05	0.000175	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EP300—conduct disorder	1.89e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EP300—conduct disorder	1.86e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EP300—conduct disorder	1.86e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.82e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.7e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—EP300—conduct disorder	1.32e-05	0.000114	CbGpPWpGaD
